Q1 results: Revenue up 11% at Rs 406 cr, PAT rises 8% to Rs 56 cr
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Indraprastha Medical Corp (Indraprastha Apollo Hospitals) reported Q1 FY27 results. Revenue from operations rose 11.3% YoY to Rs 406.15 cr from Rs 365.06 cr. PAT grew 8.5% to Rs 55.85 cr from Rs 51.46 cr. PBT stood at Rs 74.82 cr, up 9.5%. EPS was Rs 6.09 vs Rs 5.61. No exceptional items. Limited review report by S N Dhawan and Co was clean with no qualifications. Board fixed 18 Sep 2026 as record date for FY26 dividend. AGM scheduled for 24 Sep 2026 via video conferencing.
Steady revenue and profit growth with clean audit report. Dividend record date set, so shareholders on books by 18 Sep are eligible for FY26 dividend.